Abstract
Drug induced leukocytoclastic vasculitis is defined as the inflammation of blood vessels caused by the use of pharmacological agents. It may only affect the skin, resulting in cutaneous leukocytoclastic vasculitis, or it may be systemic, affecting other organs such as central nervous system, gastrointestinal tract, lungs, kidneys, and joints resulting is organ and tissue damage and even death. Early withdrawal of the causative drug is sufficient to promote rapid resolution and recovery. Here we report a case of tigecycline induced cutaneous leukocytoclastic vasculitis of hemorrhagic vesiculobullous type in an immunocompromised patient who was being treated with tigecycline for parapneumonic effusion with persistently elevated inflammatory markers.
Keywords
Publication details
- Journal
- Oman Medical Journal, 41(2)
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
- License
- CC BY-NC 4.0
Cite this article
APA 7
Al Maqbali, H., Al Majrabi, B., Al-Waili, A., Qureshi, A., Balkhair, A., & Al Busaidi, I. (2026). Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation. Oman Medical Journal, 41(2). https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation
MLA 9
Al Maqbali, Huda, et al. "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation." Oman Medical Journal, vol. 41, no. 2, 2026. https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
Chicago (author–date)
Al Maqbali, Huda, Belkees Al Majrabi, Ahmed Al-Waili, Asim Qureshi, Abullah Balkhair, and Ibrahim Al Busaidi. 2026. "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation." Oman Medical Journal 41 (2). https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
Harvard
Al Maqbali, H., Al Majrabi, B., Al-Waili, A., Qureshi, A., Balkhair, A. and Al Busaidi, I. (2026) 'Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation', Oman Medical Journal, 41(2). Available at: https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
Vancouver
Al Maqbali H, Al Majrabi B, Al-Waili A, Qureshi A, Balkhair A, Al Busaidi I. Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation. Oman Medical Journal. 2026;41(2). https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation
IEEE
H. Al Maqbali, B. Al Majrabi, A. Al-Waili, A. Qureshi, A. Balkhair, and I. Al Busaidi, "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation," Oman Medical Journal, vol. 41, no. 2, 2026, https://omanscience.com/en/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.